GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Margin of Safety % (DCF Dividends Based)

Dechra Pharmaceuticals (LSE:DPH) Margin of Safety % (DCF Dividends Based) : -114.66% (As of May. 20, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Dechra Pharmaceuticals Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

As of today (2024-05-20), Dechra Pharmaceuticals's Predictability Rank is 3-Stars. Dechra Pharmaceuticals's intrinsic value calculated from the Discounted Dividend model is £21.40 and current share price is £38.66. Consequently,

Dechra Pharmaceuticals's Margin of Safety % (DCF Dividends Based) using Discounted Dividend model is -114.66%.

Competitive Comparison of Dechra Pharmaceuticals's Margin of Safety % (DCF Dividends Based)

For the Drug Manufacturers - General subindustry, Dechra Pharmaceuticals's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dechra Pharmaceuticals's Margin of Safety % (DCF Dividends Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dechra Pharmaceuticals's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Dechra Pharmaceuticals's Margin of Safety % (DCF Dividends Based) falls into.


Dechra Pharmaceuticals Margin of Safety % (DCF Dividends Based) Calculation

Dechra Pharmaceuticals's Margin of Safety % (DCF Dividends Based) for today is calculated as

Margin of Safety % (DCF Dividends Based)=(Intrinsic Value: DCF (Dividends Based)-Current Price)/Intrinsic Value: DCF (Dividends Based)
=(18.01-38.66)/18.01
=-114.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Dividend model with default parameters.

Dechra Pharmaceuticals Margin of Safety % (DCF Dividends Based) Related Terms

Thank you for viewing the detailed overview of Dechra Pharmaceuticals's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Dechra Pharmaceuticals (LSE:DPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dechra Pharmaceuticals PLC (LSE:DPH) » Definitions » Margin of Safety % (DCF Dividends Based)
Comparable Companies
LSE:VOX LSE:CMB LSE:BLU LSE:SDVP LSE:ARGO LSE:INV LSE:WCW LSE:WINV LSE:SVM LSE:BRH LLY JNJ MRK ABBV XSWX:ROG XSWX:NOVN LSE:AZN AMGN PFE XPAR:SAN
Traded in Other Exchanges
DPHAY:USA DPHl:UK 1PK:Germany
Address
24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, GBR, CW9 7UA
Website
https://www.dechra.com
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.

Dechra Pharmaceuticals (LSE:DPH) Headlines

No Headlines